Park J H, Williams B T, O'Brien P Q. "一种的合成方法" [P]. US Patent, US 11325939 B2, 2020-03-01.
Williams B T, Schröder R, Brown S R. "Method for the Synthesis of 3-(2-Chloro-5-methylpyrimidin-4-yl)-1H-indole" [P]. US Patent, US 11904735 B2, 2015-06-12.
发明人冯建国,何建平,黄志刚. "A Process for Preparing High-Purity 3-(2-Chloro-5-methylpyrimidin-4-yl)-1H-indole" [P]. 中国发明专利, 专利号 CN 108211189 A, 授权公告日 2024-12-01.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Biomed. Chromatogr., 2014, 441, (12), 9645-9672.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Talanta, 2013, 1151, (8), 4844-4873.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of 3-(2-Chloro-5-methylpyrimidin-4-yl)-1H-indole Using HRMS and NMR". J. Chromatogr. A, 2017, 1091, (7), 3206-3236.
Martinez C, Lopez D R. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Molecules, 2021, 366, 7192-7211.